Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$1.9 million.

  • Cumberland Pharmaceuticals' Consolidated Net Income fell 26.81% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.22%. This contributed to the annual value of -$6.4 million for FY2024, which is 1.78% down from last year.
  • Cumberland Pharmaceuticals' Consolidated Net Income amounted to -$1.9 million in Q3 2025, which was down 165.10% from -$735,207 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Consolidated Net Income's 5-year high stood at $1.2 million during Q1 2025, with a 5-year trough of -$6.3 million in Q4 2023.
  • Moreover, its 3-year median value for Consolidated Net Income was -$1.1 million (2024), whereas its average is -$1.3 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Consolidated Net Income slumped by 1,204.25% in 2024 and then surged by 165.61% in 2025.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Consolidated Net Income stood at $503,318 in 2021, then slumped by 588.70% to -$2.5 million in 2022, then slumped by 156.21% to -$6.3 million in 2023, then surged by 69.82% to -$1.9 million in 2024, then decreased by 26.81% to -$1.9 million in 2025.
  • Its last three reported values are -$1.9 million in Q3 2025, -$735,207 for Q2 2025, and $1.2 million during Q1 2025.